<p>Platelets were pretreated with 5 μ M nifedipine or nifedipine combined with various drugs for 3 min followed by addition of collagen for 6 min. The expression of phospho-P38MAPK and total-P38MAPK (A), phospho-ERK1/2 and total ERK1/2 (B), phospho-HSP27 and total-HSP27 (C) were determined. Date were expressed as means ± SEM (<i>n</i> = 5). <sup>***</sup><i>p</i> < 0.001 compared with collagen alone group; <sup>++</sup><i>p</i> < 0.01, <sup>+++</sup><i>p</i> < 0.001 compared with respective collagen+nifedipine-treated group.</p
Univ Talca, Fac Hlth Sci, Dept Clin Biochem & Immunohaematol, Interdisciplinary Excellence Res Progr...
<p>PRP was pretreated with various doses of rivaroxaban (A) or edoxaban (B) for 15 min, and then sti...
Objective—Nifedipine, an L-type calcium channel blocker, protects against the progression of atheros...
<p>Platelets were treated with nifedipine (5 μ M), or nifedipine combined with various drugs for 3 m...
<p>Platelets were preincubated with nifedipine or nifedipine combined with GSK0660 or GW9662 for 3 m...
<p>Platelets were incubated with various drugs, followed by addition of collagen. The levels of NOx ...
[[abstract]]OBJECTIVE: Nifedipine, an L-type calcium channel blocker, is widely used in the treatmen...
The platelet-derived soluble CD40L (sCD40L) release plays a critical role in the development of athe...
<div><p>The platelet-derived soluble CD40L (sCD40L) release plays a critical role in the development...
<p>Washed platelets were preincubated with various doses of nifedipine or nifedipine combined with G...
<p>Primary HLFs were pretreated with PPAR-γ ligands; CDDO (1µM) and 15d-PGJ<sub>2</sub> (5µM) follow...
<p>PRP was pretreated with various doses of rivaroxaban (A) or edoxaban (B) for 15 min, and then sti...
<p>(A) After MIN6 cells were co-treated with nifedipine and 0.5 mM PA for 48 h, the phosphorylation ...
<p><b>a</b> Differentiated adipocytes were incubated with 50 µmol/L LA (L) or <i>t</i>10<i>c</i>12 C...
<p><b>Copyright information:</b></p><p>Taken from "Nifedipine protects against overproduction of sup...
Univ Talca, Fac Hlth Sci, Dept Clin Biochem & Immunohaematol, Interdisciplinary Excellence Res Progr...
<p>PRP was pretreated with various doses of rivaroxaban (A) or edoxaban (B) for 15 min, and then sti...
Objective—Nifedipine, an L-type calcium channel blocker, protects against the progression of atheros...
<p>Platelets were treated with nifedipine (5 μ M), or nifedipine combined with various drugs for 3 m...
<p>Platelets were preincubated with nifedipine or nifedipine combined with GSK0660 or GW9662 for 3 m...
<p>Platelets were incubated with various drugs, followed by addition of collagen. The levels of NOx ...
[[abstract]]OBJECTIVE: Nifedipine, an L-type calcium channel blocker, is widely used in the treatmen...
The platelet-derived soluble CD40L (sCD40L) release plays a critical role in the development of athe...
<div><p>The platelet-derived soluble CD40L (sCD40L) release plays a critical role in the development...
<p>Washed platelets were preincubated with various doses of nifedipine or nifedipine combined with G...
<p>Primary HLFs were pretreated with PPAR-γ ligands; CDDO (1µM) and 15d-PGJ<sub>2</sub> (5µM) follow...
<p>PRP was pretreated with various doses of rivaroxaban (A) or edoxaban (B) for 15 min, and then sti...
<p>(A) After MIN6 cells were co-treated with nifedipine and 0.5 mM PA for 48 h, the phosphorylation ...
<p><b>a</b> Differentiated adipocytes were incubated with 50 µmol/L LA (L) or <i>t</i>10<i>c</i>12 C...
<p><b>Copyright information:</b></p><p>Taken from "Nifedipine protects against overproduction of sup...
Univ Talca, Fac Hlth Sci, Dept Clin Biochem & Immunohaematol, Interdisciplinary Excellence Res Progr...
<p>PRP was pretreated with various doses of rivaroxaban (A) or edoxaban (B) for 15 min, and then sti...
Objective—Nifedipine, an L-type calcium channel blocker, protects against the progression of atheros...